Booth Bruce's Form 4 filing
Vigil Neuroscience, Inc.VIGL · filed Jan 11, 2022
- Accession no.
- 0000899243-22-001651
- Filed
- Jan 11, 2022
- Trade date
- Jan 11, 2022
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market purchases total $7.49M. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Booth BruceCIK 0001451612 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 11, 2022 | Common Stock | CConversionAcquired | +2,831,520 | –F1 | – | 4,273,896 | Indirect | |
| Jan 11, 2022 | Common Stock | CConversionAcquired | +1,027,978 | –F1 | – | 1,027,978 | Indirect | |
| Jan 11, 2022 | Common Stock | PPurchaseAcquired | +535,000 | $14.00F4 | +$7,490,000 | 4,808,896 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 11, 2022 | Common Stock | CConversionDisposed | −2,831,520 | $0.00 | $0 | 0 | Indirect | |
| Jan 11, 2022 | Common Stock | CConversionDisposed | −1,027,978 | $0.00 | $0 | 0 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock") on a one-for-2.7732 basis upon the closing of the Issuer's initial public offering on January 11, 2022 and had no expiration date.
Referenced by the price of 2 transactions in Table I.
- F4
On January 11, 2022, Atlas Venture Fund XII purchased 535,000 shares of Common Stock of the Issuer at a price of $14.00 per share pursuant to an underwritten public offering.
Referenced by the price of 1 transaction in Table I.